NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

EPIX Pharmaceuticals, Inc. 

4 Maguire Road

Lexington  Massachusetts  02421  U.S.A.
Phone: 781-761-7600 Fax: 781-761-7632


SEARCH JOBS

View Clinical Trials from BioPharm Insight

EPIX Pharmaceuticals is a biopharmaceutical company focused on discovering and developing novel therapeutics through the use of its proprietary and highly efficient in silico drug discovery platform. The company has a pipeline of internally-discovered drug candidates currently in clinical development to treat diseases of the central nervous system and lung conditions. EPIX also has collaborations with leading organizations, including GlaxoSmithKline, Amgen, Cystic Fibrosis Foundation Therapeutics, and Bayer Schering Pharma AG, Germany.

For more information about EPIX, please visit the company’s website at www.epixpharma.com.

 Key Statistics


Email: info@epixpharma.com
Ownership:
Web Site: EPIX Pharmaceuticals, Inc.
Employees: 100
Symbol: EPIX
 



Industry
Biotechnology






 Company News
EPIX Pharmaceuticals, Inc. (EPIX) Announces FDA Approval of a Physician-Sponsored IND for Fourth 6-month Open Label Extension of PRX-03140 for Alzheimer's Disease Patient 10/16/2009 11:09:03 AM    More...
EPIX Pharmaceuticals, Inc. (EPIX) Announces a Successful Auction Sale of Five Drug Program Intellectual Properties on September 30, 2009 10/1/2009 10:33:03 AM    More...
EPIX Pharmaceuticals, Inc. (EPIX) Announces the PRX-00023 Therapeutics CNS Program in Phase 2b/3 Will Be Part of the Intellectual Property Offered for Sale at the September 30, 2009 Auction 8/25/2009 11:20:34 AM    More...
EPIX Pharmaceuticals, Inc. (EPIX) Announces August 25, 2009 for the Auction Sale of Equipment and September 30, 2009 for the Auction Sale of the Intellectual Property 8/4/2009 8:19:49 AM    More...
EPIX Pharmaceuticals, Inc. (EPIX) Assigns all Its Assets to Joseph F. Finn, Jr., C.P.A. for the Benefit of Its Creditors 7/22/2009 9:12:11 AM    More...
EPIX Pharmaceuticals, Inc. (EPIX) Assigns All of Its Assets for the Benefit of Creditors 7/21/2009 10:03:36 AM    More...
Delisting of Securities of EPIX Pharmaceuticals, Inc. (EPIX) From The NASDAQ Stock Market 7/17/2009 8:50:14 AM    More...
EPIX Pharmaceuticals, Inc. (EPIX) Announces Noteholders' Right to Require the Company to Repurchase $3.2 Million Outstanding Balance of 3% Convertible Senior Notes Due 2024 6/4/2009 9:47:00 AM    More...
EPIX Pharmaceuticals, Inc. (EPIX) Announces Receipt of NASDAQ Panel Decision to Delist Common Stock 5/14/2009 9:10:43 AM    More...
EPIX Pharmaceuticals, Inc. (EPIX) Announces First Quarter 2009 Financial Results 5/12/2009 9:34:41 AM    More...
12345678910...